When every second counts, shaving days from a gene therapy manufacturing timeline is a huge win. What if you could eliminate months? Watch this Cell & Gene webinar where Viralgen’s Ane Quesada, PhD, and Joschka Buyel, PhD, of QbDVision share how Viralgen was able to cut onboarding time for a customer's commercial program from as much as a year down to just 3 months, making it possible to get a first-in-class gene therapy manufacturing-ready on a dramatically compressed timeline, with no loss of quality.
It’s a scalable model for future technology transfers that enables organizations to deliver therapies to patients sooner and respond to evolving market demands with agility.
Watch to see what made this possible, including:
-
A structured, science-driven approach
-
Digital frameworks
-
Standardized documentation, templates, and reporting
If you’re seeking practical strategies to streamline onboarding, enhance collaboration, and scale manufacturing readiness, this resource offers actionable insights you can apply today.
